What is ResMed's raw materials?

ResMed (RMD) reported raw materials of $350.91M in Q1 2026.

How has ResMed's raw materials changed year-over-year?

ResMed's raw materials increased by 2.3% year-over-year, from $342.99M to $350.91M.

What is the long-term trend for ResMed's raw materials?

Over 4 years (2021 to 2025), ResMed's raw materials has grown at a 24.0% compound annual growth rate (CAGR), from $155.42M to $367.28M.

What does raw materials mean?

Unprocessed materials and components purchased for use in manufacturing, valued at cost.

ResMed RMD Raw materials

Raw materials at other companies

LivaNovaLIVN

$72.31M+0.6%

Pulmonx CorporationLUNG

$4.66M+37.8%

AbbottABT

$1.72B+2.1%

Eli LillyLLY

——

MedtronicMDT

——

Baxter InternationalBAX

——

Other financials

Income statement

See full

Revenue$1.4B+10.8%

Gross profit$891.0M+16.3%

Operating income$499.8M+17.3%

Net income$398.7M+9.2%

EPS (diluted)$2.74+10.5%

Balance sheet

See full

Cash & equivalents$1.7B+78.0%

Total debt$1.1B+29.8%

Total equity$6.5B+17.1%

Total assets$8.8B+16.1%

Cash flow

See full

Operating cash flow$554.1M-4.2%

CapEx$33.7M+61.8%

Free cash flow$520.5M-6.7%

Valuation

See full

Market cap$28.27B-19.1%

Enterprise value$27.71B-19.8%

P/E18.6×-6.3×

P/S5.1×-1.7×

Profitability

See full

Gross margin61.6%+2.8pp

Operating margin34.2%+2.1pp

Net margin27.4%+1.3pp

FCF margin31.7%+0.4pp

Returns & leverage

See full

Return on equity25.2%-0.6pp

Debt / equity0.2×0.0×

Current ratio3×-0.4×

Where this comes from

Reported directly by ResMed in its filing.

Tagged under the XBRL concept us-gaap:InventoryRawMaterialsNetOfReserves.

The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about ResMed's raw materials.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ResMed's raw materials?: ResMed (RMD) reported raw materials of $350.91M in Q1 2026.
How has ResMed's raw materials changed year-over-year?: ResMed's raw materials increased by 2.3% year-over-year, from $342.99M to $350.91M.
What is the long-term trend for ResMed's raw materials?: Over 4 years (2021 to 2025), ResMed's raw materials has grown at a 24.0% compound annual growth rate (CAGR), from $155.42M to $367.28M.
What does raw materials mean?: Unprocessed materials and components purchased for use in manufacturing, valued at cost.